Altasciences Clinical Research
2017 - A Year in Review
As we look forward to what the New Year will bring, we wanted to take a moment to thank you, our clients and partners, for making 2017 a newsworthy year. Here are some of the highlights we are proud to look back on.
We opened a controlled ventilation indoor vaping room, a complement to our purpose-built smoking evaluation facility, for clinical studies for e-cigarette and vaping products.
For a 4th consecutive year, Altasciences won multiple CRO Leadership awards in the following categories: Expertise, Reliability, Quality, Capabilities and Compatibility.
Our CEO was named one of the 100 Most Inspiring Leaders in the Life Sciences industry by PharmaVOICE magazine for a third consecutive year.
Our experts presented 26 scientific posters at industry conferences, winning the “Most Outstanding Poster” award at the 13th Applied Pharmaceutical Analysis Meeting (APA).
We hosted multiple events, including 2 webinars, one on Volumetric Absorptive Microsampling
and another on The Effects of Drugs on Driving.
Our Lab analyzed over 612,552 bioanalytical samples and validated 48 assays.
We completed a safety and tolerability study on the world’s first cannabis extract being developed as a drug.
Awarded a $9.5-million, five-year contract for clinical pharmacology studies.
We launched The Altascientist, a scientific journal in which we share results from our latest case studies.
We were recognized by Neoteryx, providers of Volumetric Absorptive Microsampling technology, for doing ground-breaking work with their Mitra® microsampling devices.
LinkedIn Twitter Youtube
Algorithme Pharma Clinical Research Vince and Associates Clinical Research Algorithme Pharma USA Clinical Research

© 2018 Altasciences. All Rights Reserved.